UnivTrevesV1, PascalFrancis, Curation, bibRecord, 000001

Single-agent gemcitabine : an active and better tolerated alternative to standard cisplatin-based chemotherapy in locally advanced or metastatic non-small cell lung cancer

Identifieur interne : 000001 ( PascalFrancis/Curation ); précédent : 000000; suivant : 000002

Single-agent gemcitabine : an active and better tolerated alternative to standard cisplatin-based chemotherapy in locally advanced or metastatic non-small cell lung cancer

Auteurs : W. W. Ten Bokkel Huinink [Pays-Bas] ; B. Bergman [Suède] ; A. Chemaissani [Allemagne] ; W. Dornoff [Allemagne] ; P. Drings [Allemagne] ; P.-L. Kellokumpu-Lehtinen [Finlande] ; K. Liippo [Finlande] ; K. Mattson [Finlande] ; J. Von Pawel [Allemagne] ; S. Ricci [Italie] ; C. Sederholm [Suède] ; R. A. Stahel [Suisse] ; G. Wagenius [Suède] ; N. V. Walree [Pays-Bas] ; C. Manegold [Allemagne]

Source :

Lung cancer [ 0169-5002 ] ; 1999.

RBID : Pascal:00-0016807

Descripteurs français

Pascal (Inist)
- Carcinome non petite cellule, Bronchopulmonaire, Gemcitabine, Chimiothérapie, Anticancéreux, Traitement, Cisplatine, Association médicamenteuse, Etude comparative, Homme, Pyrimidine nucléoside, Fluor Composé organique, Platine II Complexe.
Wicri :
- topic : Homme.

English descriptors

KwdEn :
- Antineoplastic agent, Bronchopulmonary, Chemotherapy, Cisplatin, Comparative study, Drug combination, Fluorine Organic compounds, Gemcitabine, Human, Non small cell carcinoma, Platinum II Complexes, Pyrimidine nucleoside, Treatment.

A01	`01`	`1`		`@0 0169-5002`
A02	`01`			`@0 LUCAE5`
A03		`1`		`@0 Lung cancer`
A05				`@2 26`
A06				`@2 2`
A08	`01`	`1`	`ENG`	`@1 Single-agent gemcitabine : an active and better tolerated alternative to standard cisplatin-based chemotherapy in locally advanced or metastatic non-small cell lung cancer`
A11	`01`	`1`		`@1 TEN BOKKEL HUININK (W. W.)`
A11	`02`	`1`		`@1 BERGMAN (B.)`
A11	`03`	`1`		`@1 CHEMAISSANI (A.)`
A11	`04`	`1`		`@1 DORNOFF (W.)`
A11	`05`	`1`		`@1 DRINGS (P.)`
A11	`06`	`1`		`@1 KELLOKUMPU-LEHTINEN (P.-L.)`
A11	`07`	`1`		`@1 LIIPPO (K.)`
A11	`08`	`1`		`@1 MATTSON (K.)`
A11	`09`	`1`		`@1 VON PAWEL (J.)`
A11	`10`	`1`		`@1 RICCI (S.)`
A11	`11`	`1`		`@1 SEDERHOLM (C.)`
A11	`12`	`1`		`@1 STAHEL (R. A.)`
A11	`13`	`1`		`@1 WAGENIUS (G.)`
A11	`14`	`1`		`@1 WALREE (N. V.)`
A11	`15`	`1`		`@1 MANEGOLD (C.)`
A14	`01`			`@1 The Netherlands Cancer Institute, Av. Leeuwenhoekhvis 121, Plesmanlann @2 1066 Amsterdam @3 NLD @Z 1 aut.`
A14	`02`			`@1 Salgrenska Sjukhuset @2 Gothenberg @3 SWE @Z 2 aut.`
A14	`03`			`@1 Städtisches Krankenhaus @2 Köln-Merheim @3 DEU @Z 3 aut.`
A14	`04`			`@1 Mutterhaus der Borromäerinnen @2 Trier @3 DEU @Z 4 aut.`
A14	`05`			`@1 Thoraxklinik @2 Heidelberg @3 DEU @Z 5 aut. @Z 15 aut.`
A14	`06`			`@1 Tampere University Hospital @2 Pinkonlinna @3 FIN @Z 6 aut.`
A14	`07`			`@1 Turku University Hospital @2 Paimio @3 FIN @Z 7 aut.`
A14	`08`			`@1 University Hospital @2 Helsinki @3 FIN @Z 8 aut.`
A14	`09`			`@1 Zentralkrankenhaus @2 Gauting @3 DEU @Z 9 aut.`
A14	`10`			`@1 S. Chiara Hospital @2 Pisa @3 ITA @Z 10 aut.`
A14	`11`			`@1 Universitets Sjukhuset @2 Linkoping @3 SWE @Z 11 aut.`
A14	`12`			`@1 Universitätsspital @2 Zürich @3 CHE @Z 12 aut.`
A14	`13`			`@1 Akademsika Sjukhuset @2 Uppsala @3 SWE @Z 13 aut.`
A14	`14`			`@1 Sint Antonius Ziekenhuis @2 Nieuwegein @3 NLD @Z 14 aut.`
A20				`@1 85-94`
A21				`@1 1999`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 21159 @5 354000080506360020`
A44				`@0 0000 @1 © 2000 INIST-CNRS. All rights reserved.`
A45				`@0 22 ref.`
A47	`01`	`1`		`@0 00-0016807`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Lung cancer`
A66	`01`			`@0 IRL`
C02	`01`	`X`		`@0 002B02R02`
C03	`01`	`X`	`FRE`	`@0 Carcinome non petite cellule @5 01`
C03	`01`	`X`	`ENG`	`@0 Non small cell carcinoma @5 01`
C03	`01`	`X`	`SPA`	`@0 Carcinoma no pequeña célula @5 01`
C03	`02`	`X`	`FRE`	`@0 Bronchopulmonaire @5 02`
C03	`02`	`X`	`ENG`	`@0 Bronchopulmonary @5 02`
C03	`02`	`X`	`SPA`	`@0 Broncopulmonar @5 02`
C03	`03`	`X`	`FRE`	`@0 Gemcitabine @2 NK @2 FR @5 04`
C03	`03`	`X`	`ENG`	`@0 Gemcitabine @2 NK @2 FR @5 04`
C03	`03`	`X`	`SPA`	`@0 Gemcitabina @2 NK @2 FR @5 04`
C03	`04`	`X`	`FRE`	`@0 Chimiothérapie @5 05`
C03	`04`	`X`	`ENG`	`@0 Chemotherapy @5 05`
C03	`04`	`X`	`SPA`	`@0 Quimioterapia @5 05`
C03	`05`	`X`	`FRE`	`@0 Anticancéreux @5 06`
C03	`05`	`X`	`ENG`	`@0 Antineoplastic agent @5 06`
C03	`05`	`X`	`SPA`	`@0 Anticanceroso @5 06`
C03	`06`	`X`	`FRE`	`@0 Traitement @5 07`
C03	`06`	`X`	`ENG`	`@0 Treatment @5 07`
C03	`06`	`X`	`SPA`	`@0 Tratamiento @5 07`
C03	`07`	`X`	`FRE`	`@0 Cisplatine @2 NK @2 FR @5 10`
C03	`07`	`X`	`ENG`	`@0 Cisplatin @2 NK @2 FR @5 10`
C03	`07`	`X`	`SPA`	`@0 Cisplatino @2 NK @2 FR @5 10`
C03	`08`	`X`	`FRE`	`@0 Association médicamenteuse @5 11`
C03	`08`	`X`	`ENG`	`@0 Drug combination @5 11`
C03	`08`	`X`	`SPA`	`@0 Asociación medicamentosa @5 11`
C03	`09`	`X`	`FRE`	`@0 Etude comparative @5 17`
C03	`09`	`X`	`ENG`	`@0 Comparative study @5 17`
C03	`09`	`X`	`SPA`	`@0 Estudio comparativo @5 17`
C03	`10`	`X`	`FRE`	`@0 Homme @5 20`
C03	`10`	`X`	`ENG`	`@0 Human @5 20`
C03	`10`	`X`	`SPA`	`@0 Hombre @5 20`
C03	`11`	`X`	`FRE`	`@0 Pyrimidine nucléoside @5 27`
C03	`11`	`X`	`ENG`	`@0 Pyrimidine nucleoside @5 27`
C03	`11`	`X`	`SPA`	`@0 Pirimidina nucleósido @5 27`
C03	`12`	`X`	`FRE`	`@0 Fluor Composé organique @2 NC @2 FX @2 NA @5 28`
C03	`12`	`X`	`ENG`	`@0 Fluorine Organic compounds @2 NC @2 FX @2 NA @5 28`
C03	`12`	`X`	`SPA`	`@0 Fluor Compuesto orgánico @2 NC @2 FX @2 NA @5 28`
C03	`13`	`X`	`FRE`	`@0 Platine II Complexe @2 NC @2 NA @5 31 @6 Platine «II» Complexe`
C03	`13`	`X`	`ENG`	`@0 Platinum II Complexes @2 NC @2 NA @5 31 @6 Platinum «II» Complexes`
C03	`13`	`X`	`SPA`	`@0 Platino II Complejo @2 NC @2 NA @5 31 @6 Platino «II» Complejo`
C07	`01`	`X`	`FRE`	`@0 Appareil respiratoire pathologie @5 37`
C07	`01`	`X`	`ENG`	`@0 Respiratory disease @5 37`
C07	`01`	`X`	`SPA`	`@0 Aparato respiratorio patología @5 37`
C07	`02`	`X`	`FRE`	`@0 Poumon pathologie @5 38`
C07	`02`	`X`	`ENG`	`@0 Lung disease @5 38`
C07	`02`	`X`	`SPA`	`@0 Pulmón patología @5 38`
C07	`03`	`X`	`FRE`	`@0 Bronche pathologie @5 39`
C07	`03`	`X`	`ENG`	`@0 Bronchus disease @5 39`
C07	`03`	`X`	`SPA`	`@0 Bronquio patología @5 39`
C07	`04`	`X`	`FRE`	`@0 Tumeur maligne @5 40`
C07	`04`	`X`	`ENG`	`@0 Malignant tumor @5 40`
C07	`04`	`X`	`SPA`	`@0 Tumor maligno @5 40`
N21				`@1 010`

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000F68

Links to Exploration step

Pascal:00-0016807

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Single-agent gemcitabine : an active and better tolerated alternative to standard cisplatin-based chemotherapy in locally advanced or metastatic non-small cell lung cancer</title>
<author><name sortKey="Ten Bokkel Huinink, W W" sort="Ten Bokkel Huinink, W W" uniqKey="Ten Bokkel Huinink W" first="W. W." last="Ten Bokkel Huinink">W. W. Ten Bokkel Huinink</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>The Netherlands Cancer Institute, Av. Leeuwenhoekhvis 121, Plesmanlann</s1>
<s2>1066 Amsterdam</s2>
<s3>NLD</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Pays-Bas</country>
</affiliation>
</author>
<author><name sortKey="Bergman, B" sort="Bergman, B" uniqKey="Bergman B" first="B." last="Bergman">B. Bergman</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Salgrenska Sjukhuset</s1>
<s2>Gothenberg</s2>
<s3>SWE</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Suède</country>
</affiliation>
</author>
<author><name sortKey="Chemaissani, A" sort="Chemaissani, A" uniqKey="Chemaissani A" first="A." last="Chemaissani">A. Chemaissani</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Städtisches Krankenhaus</s1>
<s2>Köln-Merheim</s2>
<s3>DEU</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
<author><name sortKey="Dornoff, W" sort="Dornoff, W" uniqKey="Dornoff W" first="W." last="Dornoff">W. Dornoff</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Mutterhaus der Borromäerinnen</s1>
<s2>Trier</s2>
<s3>DEU</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
<author><name sortKey="Drings, P" sort="Drings, P" uniqKey="Drings P" first="P." last="Drings">P. Drings</name>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Thoraxklinik</s1>
<s2>Heidelberg</s2>
<s3>DEU</s3>
<sZ>5 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
<author><name sortKey="Kellokumpu Lehtinen, P L" sort="Kellokumpu Lehtinen, P L" uniqKey="Kellokumpu Lehtinen P" first="P.-L." last="Kellokumpu-Lehtinen">P.-L. Kellokumpu-Lehtinen</name>
<affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Tampere University Hospital</s1>
<s2>Pinkonlinna</s2>
<s3>FIN</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Finlande</country>
</affiliation>
</author>
<author><name sortKey="Liippo, K" sort="Liippo, K" uniqKey="Liippo K" first="K." last="Liippo">K. Liippo</name>
<affiliation wicri:level="1"><inist:fA14 i1="07"><s1>Turku University Hospital</s1>
<s2>Paimio</s2>
<s3>FIN</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Finlande</country>
</affiliation>
</author>
<author><name sortKey="Mattson, K" sort="Mattson, K" uniqKey="Mattson K" first="K." last="Mattson">K. Mattson</name>
<affiliation wicri:level="1"><inist:fA14 i1="08"><s1>University Hospital</s1>
<s2>Helsinki</s2>
<s3>FIN</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Finlande</country>
</affiliation>
</author>
<author><name sortKey="Von Pawel, J" sort="Von Pawel, J" uniqKey="Von Pawel J" first="J." last="Von Pawel">J. Von Pawel</name>
<affiliation wicri:level="1"><inist:fA14 i1="09"><s1>Zentralkrankenhaus</s1>
<s2>Gauting</s2>
<s3>DEU</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
<author><name sortKey="Ricci, S" sort="Ricci, S" uniqKey="Ricci S" first="S." last="Ricci">S. Ricci</name>
<affiliation wicri:level="1"><inist:fA14 i1="10"><s1>S. Chiara Hospital</s1>
<s2>Pisa</s2>
<s3>ITA</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author><name sortKey="Sederholm, C" sort="Sederholm, C" uniqKey="Sederholm C" first="C." last="Sederholm">C. Sederholm</name>
<affiliation wicri:level="1"><inist:fA14 i1="11"><s1>Universitets Sjukhuset</s1>
<s2>Linkoping</s2>
<s3>SWE</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Suède</country>
</affiliation>
</author>
<author><name sortKey="Stahel, R A" sort="Stahel, R A" uniqKey="Stahel R" first="R. A." last="Stahel">R. A. Stahel</name>
<affiliation wicri:level="1"><inist:fA14 i1="12"><s1>Universitätsspital</s1>
<s2>Zürich</s2>
<s3>CHE</s3>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>Suisse</country>
</affiliation>
</author>
<author><name sortKey="Wagenius, G" sort="Wagenius, G" uniqKey="Wagenius G" first="G." last="Wagenius">G. Wagenius</name>
<affiliation wicri:level="1"><inist:fA14 i1="13"><s1>Akademsika Sjukhuset</s1>
<s2>Uppsala</s2>
<s3>SWE</s3>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>Suède</country>
</affiliation>
</author>
<author><name sortKey="Walree, N V" sort="Walree, N V" uniqKey="Walree N" first="N. V." last="Walree">N. V. Walree</name>
<affiliation wicri:level="1"><inist:fA14 i1="14"><s1>Sint Antonius Ziekenhuis</s1>
<s2>Nieuwegein</s2>
<s3>NLD</s3>
<sZ>14 aut.</sZ>
</inist:fA14>
<country>Pays-Bas</country>
</affiliation>
</author>
<author><name sortKey="Manegold, C" sort="Manegold, C" uniqKey="Manegold C" first="C." last="Manegold">C. Manegold</name>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Thoraxklinik</s1>
<s2>Heidelberg</s2>
<s3>DEU</s3>
<sZ>5 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">00-0016807</idno>
<date when="1999">1999</date>
<idno type="stanalyst">PASCAL 00-0016807 INIST</idno>
<idno type="RBID">Pascal:00-0016807</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000F68</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000001</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Single-agent gemcitabine : an active and better tolerated alternative to standard cisplatin-based chemotherapy in locally advanced or metastatic non-small cell lung cancer</title>
<author><name sortKey="Ten Bokkel Huinink, W W" sort="Ten Bokkel Huinink, W W" uniqKey="Ten Bokkel Huinink W" first="W. W." last="Ten Bokkel Huinink">W. W. Ten Bokkel Huinink</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>The Netherlands Cancer Institute, Av. Leeuwenhoekhvis 121, Plesmanlann</s1>
<s2>1066 Amsterdam</s2>
<s3>NLD</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Pays-Bas</country>
</affiliation>
</author>
<author><name sortKey="Bergman, B" sort="Bergman, B" uniqKey="Bergman B" first="B." last="Bergman">B. Bergman</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Salgrenska Sjukhuset</s1>
<s2>Gothenberg</s2>
<s3>SWE</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Suède</country>
</affiliation>
</author>
<author><name sortKey="Chemaissani, A" sort="Chemaissani, A" uniqKey="Chemaissani A" first="A." last="Chemaissani">A. Chemaissani</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Städtisches Krankenhaus</s1>
<s2>Köln-Merheim</s2>
<s3>DEU</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
<author><name sortKey="Dornoff, W" sort="Dornoff, W" uniqKey="Dornoff W" first="W." last="Dornoff">W. Dornoff</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Mutterhaus der Borromäerinnen</s1>
<s2>Trier</s2>
<s3>DEU</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
<author><name sortKey="Drings, P" sort="Drings, P" uniqKey="Drings P" first="P." last="Drings">P. Drings</name>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Thoraxklinik</s1>
<s2>Heidelberg</s2>
<s3>DEU</s3>
<sZ>5 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
<author><name sortKey="Kellokumpu Lehtinen, P L" sort="Kellokumpu Lehtinen, P L" uniqKey="Kellokumpu Lehtinen P" first="P.-L." last="Kellokumpu-Lehtinen">P.-L. Kellokumpu-Lehtinen</name>
<affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Tampere University Hospital</s1>
<s2>Pinkonlinna</s2>
<s3>FIN</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Finlande</country>
</affiliation>
</author>
<author><name sortKey="Liippo, K" sort="Liippo, K" uniqKey="Liippo K" first="K." last="Liippo">K. Liippo</name>
<affiliation wicri:level="1"><inist:fA14 i1="07"><s1>Turku University Hospital</s1>
<s2>Paimio</s2>
<s3>FIN</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Finlande</country>
</affiliation>
</author>
<author><name sortKey="Mattson, K" sort="Mattson, K" uniqKey="Mattson K" first="K." last="Mattson">K. Mattson</name>
<affiliation wicri:level="1"><inist:fA14 i1="08"><s1>University Hospital</s1>
<s2>Helsinki</s2>
<s3>FIN</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Finlande</country>
</affiliation>
</author>
<author><name sortKey="Von Pawel, J" sort="Von Pawel, J" uniqKey="Von Pawel J" first="J." last="Von Pawel">J. Von Pawel</name>
<affiliation wicri:level="1"><inist:fA14 i1="09"><s1>Zentralkrankenhaus</s1>
<s2>Gauting</s2>
<s3>DEU</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
<author><name sortKey="Ricci, S" sort="Ricci, S" uniqKey="Ricci S" first="S." last="Ricci">S. Ricci</name>
<affiliation wicri:level="1"><inist:fA14 i1="10"><s1>S. Chiara Hospital</s1>
<s2>Pisa</s2>
<s3>ITA</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author><name sortKey="Sederholm, C" sort="Sederholm, C" uniqKey="Sederholm C" first="C." last="Sederholm">C. Sederholm</name>
<affiliation wicri:level="1"><inist:fA14 i1="11"><s1>Universitets Sjukhuset</s1>
<s2>Linkoping</s2>
<s3>SWE</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Suède</country>
</affiliation>
</author>
<author><name sortKey="Stahel, R A" sort="Stahel, R A" uniqKey="Stahel R" first="R. A." last="Stahel">R. A. Stahel</name>
<affiliation wicri:level="1"><inist:fA14 i1="12"><s1>Universitätsspital</s1>
<s2>Zürich</s2>
<s3>CHE</s3>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>Suisse</country>
</affiliation>
</author>
<author><name sortKey="Wagenius, G" sort="Wagenius, G" uniqKey="Wagenius G" first="G." last="Wagenius">G. Wagenius</name>
<affiliation wicri:level="1"><inist:fA14 i1="13"><s1>Akademsika Sjukhuset</s1>
<s2>Uppsala</s2>
<s3>SWE</s3>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>Suède</country>
</affiliation>
</author>
<author><name sortKey="Walree, N V" sort="Walree, N V" uniqKey="Walree N" first="N. V." last="Walree">N. V. Walree</name>
<affiliation wicri:level="1"><inist:fA14 i1="14"><s1>Sint Antonius Ziekenhuis</s1>
<s2>Nieuwegein</s2>
<s3>NLD</s3>
<sZ>14 aut.</sZ>
</inist:fA14>
<country>Pays-Bas</country>
</affiliation>
</author>
<author><name sortKey="Manegold, C" sort="Manegold, C" uniqKey="Manegold C" first="C." last="Manegold">C. Manegold</name>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Thoraxklinik</s1>
<s2>Heidelberg</s2>
<s3>DEU</s3>
<sZ>5 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Lung cancer</title>
<title level="j" type="abbreviated">Lung cancer</title>
<idno type="ISSN">0169-5002</idno>
<imprint><date when="1999">1999</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Lung cancer</title>
<title level="j" type="abbreviated">Lung cancer</title>
<idno type="ISSN">0169-5002</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antineoplastic agent</term>
<term>Bronchopulmonary</term>
<term>Chemotherapy</term>
<term>Cisplatin</term>
<term>Comparative study</term>
<term>Drug combination</term>
<term>Fluorine Organic compounds</term>
<term>Gemcitabine</term>
<term>Human</term>
<term>Non small cell carcinoma</term>
<term>Platinum II Complexes</term>
<term>Pyrimidine nucleoside</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Carcinome non petite cellule</term>
<term>Bronchopulmonaire</term>
<term>Gemcitabine</term>
<term>Chimiothérapie</term>
<term>Anticancéreux</term>
<term>Traitement</term>
<term>Cisplatine</term>
<term>Association médicamenteuse</term>
<term>Etude comparative</term>
<term>Homme</term>
<term>Pyrimidine nucléoside</term>
<term>Fluor Composé organique</term>
<term>Platine II Complexe</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0169-5002</s0>
</fA01>
<fA02 i1="01"><s0>LUCAE5</s0>
</fA02>
<fA03 i2="1"><s0>Lung cancer</s0>
</fA03>
<fA05><s2>26</s2>
</fA05>
<fA06><s2>2</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Single-agent gemcitabine : an active and better tolerated alternative to standard cisplatin-based chemotherapy in locally advanced or metastatic non-small cell lung cancer</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>TEN BOKKEL HUININK (W. W.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>BERGMAN (B.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>CHEMAISSANI (A.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>DORNOFF (W.)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>DRINGS (P.)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>KELLOKUMPU-LEHTINEN (P.-L.)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>LIIPPO (K.)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>MATTSON (K.)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>VON PAWEL (J.)</s1>
</fA11>
<fA11 i1="10" i2="1"><s1>RICCI (S.)</s1>
</fA11>
<fA11 i1="11" i2="1"><s1>SEDERHOLM (C.)</s1>
</fA11>
<fA11 i1="12" i2="1"><s1>STAHEL (R. A.)</s1>
</fA11>
<fA11 i1="13" i2="1"><s1>WAGENIUS (G.)</s1>
</fA11>
<fA11 i1="14" i2="1"><s1>WALREE (N. V.)</s1>
</fA11>
<fA11 i1="15" i2="1"><s1>MANEGOLD (C.)</s1>
</fA11>
<fA14 i1="01"><s1>The Netherlands Cancer Institute, Av. Leeuwenhoekhvis 121, Plesmanlann</s1>
<s2>1066 Amsterdam</s2>
<s3>NLD</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Salgrenska Sjukhuset</s1>
<s2>Gothenberg</s2>
<s3>SWE</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Städtisches Krankenhaus</s1>
<s2>Köln-Merheim</s2>
<s3>DEU</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Mutterhaus der Borromäerinnen</s1>
<s2>Trier</s2>
<s3>DEU</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="05"><s1>Thoraxklinik</s1>
<s2>Heidelberg</s2>
<s3>DEU</s3>
<sZ>5 aut.</sZ>
<sZ>15 aut.</sZ>
</fA14>
<fA14 i1="06"><s1>Tampere University Hospital</s1>
<s2>Pinkonlinna</s2>
<s3>FIN</s3>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="07"><s1>Turku University Hospital</s1>
<s2>Paimio</s2>
<s3>FIN</s3>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="08"><s1>University Hospital</s1>
<s2>Helsinki</s2>
<s3>FIN</s3>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="09"><s1>Zentralkrankenhaus</s1>
<s2>Gauting</s2>
<s3>DEU</s3>
<sZ>9 aut.</sZ>
</fA14>
<fA14 i1="10"><s1>S. Chiara Hospital</s1>
<s2>Pisa</s2>
<s3>ITA</s3>
<sZ>10 aut.</sZ>
</fA14>
<fA14 i1="11"><s1>Universitets Sjukhuset</s1>
<s2>Linkoping</s2>
<s3>SWE</s3>
<sZ>11 aut.</sZ>
</fA14>
<fA14 i1="12"><s1>Universitätsspital</s1>
<s2>Zürich</s2>
<s3>CHE</s3>
<sZ>12 aut.</sZ>
</fA14>
<fA14 i1="13"><s1>Akademsika Sjukhuset</s1>
<s2>Uppsala</s2>
<s3>SWE</s3>
<sZ>13 aut.</sZ>
</fA14>
<fA14 i1="14"><s1>Sint Antonius Ziekenhuis</s1>
<s2>Nieuwegein</s2>
<s3>NLD</s3>
<sZ>14 aut.</sZ>
</fA14>
<fA20><s1>85-94</s1>
</fA20>
<fA21><s1>1999</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>21159</s2>
<s5>354000080506360020</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2000 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>22 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>00-0016807</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Lung cancer</s0>
</fA64>
<fA66 i1="01"><s0>IRL</s0>
</fA66>
<fC02 i1="01" i2="X"><s0>002B02R02</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Carcinome non petite cellule</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Non small cell carcinoma</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Carcinoma no pequeña célula</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Bronchopulmonaire</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Bronchopulmonary</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Broncopulmonar</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Gemcitabine</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Gemcitabine</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Gemcitabina</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Chimiothérapie</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Chemotherapy</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Quimioterapia</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Anticancéreux</s0>
<s5>06</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Antineoplastic agent</s0>
<s5>06</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Anticanceroso</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Traitement</s0>
<s5>07</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Treatment</s0>
<s5>07</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Tratamiento</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Cisplatine</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>10</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Cisplatin</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>10</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Cisplatino</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>10</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Association médicamenteuse</s0>
<s5>11</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Drug combination</s0>
<s5>11</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Asociación medicamentosa</s0>
<s5>11</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Etude comparative</s0>
<s5>17</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Comparative study</s0>
<s5>17</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Estudio comparativo</s0>
<s5>17</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Homme</s0>
<s5>20</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Human</s0>
<s5>20</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Hombre</s0>
<s5>20</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Pyrimidine nucléoside</s0>
<s5>27</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Pyrimidine nucleoside</s0>
<s5>27</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Pirimidina nucleósido</s0>
<s5>27</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE"><s0>Fluor Composé organique</s0>
<s2>NC</s2>
<s2>FX</s2>
<s2>NA</s2>
<s5>28</s5>
</fC03>
<fC03 i1="12" i2="X" l="ENG"><s0>Fluorine Organic compounds</s0>
<s2>NC</s2>
<s2>FX</s2>
<s2>NA</s2>
<s5>28</s5>
</fC03>
<fC03 i1="12" i2="X" l="SPA"><s0>Fluor Compuesto orgánico</s0>
<s2>NC</s2>
<s2>FX</s2>
<s2>NA</s2>
<s5>28</s5>
</fC03>
<fC03 i1="13" i2="X" l="FRE"><s0>Platine II Complexe</s0>
<s2>NC</s2>
<s2>NA</s2>
<s5>31</s5>
<s6>Platine «II» Complexe</s6>
</fC03>
<fC03 i1="13" i2="X" l="ENG"><s0>Platinum II Complexes</s0>
<s2>NC</s2>
<s2>NA</s2>
<s5>31</s5>
<s6>Platinum «II» Complexes</s6>
</fC03>
<fC03 i1="13" i2="X" l="SPA"><s0>Platino II Complejo</s0>
<s2>NC</s2>
<s2>NA</s2>
<s5>31</s5>
<s6>Platino «II» Complejo</s6>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Appareil respiratoire pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Respiratory disease</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Aparato respiratorio patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Poumon pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Lung disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Pulmón patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Bronche pathologie</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Bronchus disease</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Bronquio patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Tumeur maligne</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Malignant tumor</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Tumor maligno</s0>
<s5>40</s5>
</fC07>
<fN21><s1>010</s1>
</fN21>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Rhénanie/explor/UnivTrevesV1/Data/PascalFrancis/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000001 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 000001 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Rhénanie
   |area=    UnivTrevesV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:00-0016807
   |texte=   Single-agent gemcitabine : an active and better tolerated alternative to standard cisplatin-based chemotherapy in locally advanced or metastatic non-small cell lung cancer
}}

This area was generated with Dilib version V0.6.31.
Data generation: Sat Jul 22 16:29:01 2017. Site generation: Wed Feb 28 14:55:37 2024

	Serveur d'exploration sur l'Université de Trèves
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur l'Université de Trèves

Single-agent gemcitabine : an active and better tolerated alternative to standard cisplatin-based chemotherapy in locally advanced or metastatic non-small cell lung cancer

Single-agent gemcitabine : an active and better tolerated alternative to standard cisplatin-based chemotherapy in locally advanced or metastatic non-small cell lung cancer

Source :

Descripteurs français

English descriptors

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri